S&P 500
(0.26%) 5 261.95 points
Dow J
(0.22%) 39 848 points
Nasdaq
(0.01%) 16 401 points
Oil
(2.13%) $83.08
Gas
(1.69%) $1.747
Gold
(1.31%) $2 241.70
Silver
(0.85%) $24.96
Platinum
(1.26%) $921.15
USD/EUR
(0.38%) $0.927
USD/NOK
(0.80%) $10.85
USD/GBP
(0.12%) $0.792
USD/RUB
(0.14%) $92.57

Realtime updates for Eagle Pharmaceuticals Inc [EGRX]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-04-01)

Expected move: +/- 14.72%

BUY
25.00%
return -11.13%
SELL
75.00%
return -7.98%
Last Updated28 Mar 2024 @ 15:27

5.56% $ 5.29

BUY 61892 min ago

@ $5.29

Issued: 14 Feb 2024 @ 14:56


Return: 0.00%


Previous signal: Feb 13 - 15:19


Previous signal: Sell


Return: 1.15 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 15:27):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States...

Stats
Today's Volume 41 814.00
Average Volume 234 724
Market Cap 68.70M
EPS $-0.270 ( 2023-11-09 )
Next earnings date ( $0 ) 2024-04-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 6.22
ATR14 $0.0180 (0.34%)
Insider Trading
Date Person Action Amount type
2024-02-28 Tarriff Scott Sell 2 119 Common Stock
2024-02-27 Cahill Brian Joseph Buy 3 800 Common Stock
2024-02-27 Cahill Brian Joseph Sell 1 589 Common Stock
2024-02-27 Tarriff Scott Buy 12 950 Common Stock
2024-02-27 Tarriff Scott Sell 3 154 Common Stock
INSIDER POWER
59.06
Last 99 transactions
Buy: 818 589 | Sell: 362 958

Volume Correlation

Long: -0.18 (neutral)
Short: -0.46 (neutral)
Signal:(47.598) Neutral

Eagle Pharmaceuticals Inc Correlation

10 Most Positive Correlations
RMRM0.965
SVAC0.963
PINC0.943
TLGT0.939
WMG0.936
TUEM0.926
PAIC0.924
JRJC0.923
IEP0.922
COLM0.918
10 Most Negative Correlations
AMRB-0.956
NETE-0.951
MORF-0.949
AVDL-0.931
WPRT-0.928
RXDX-0.927
NYMTN-0.92
COKE-0.919
FLMN-0.919
KBWD-0.917

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Eagle Pharmaceuticals Inc Correlation - Currency/Commodity

The country flag 0.19
( neutral )
The country flag 0.31
( neutral )
The country flag 0.00
( neutral )
The country flag 0.19
( neutral )
The country flag 0.00
( neutral )
The country flag 0.48
( neutral )

Eagle Pharmaceuticals Inc Financials

Annual 2022
Revenue: $316.61M
Gross Profit: $221.67M (70.01 %)
EPS: $2.76
Q2 2023
Revenue: $64.65M
Gross Profit: $47.79M (73.92 %)
EPS: $0.390
Q1 2023
Revenue: $66.31M
Gross Profit: $49.01M (73.91 %)
EPS: $0.440
Q4 2022
Revenue: $60.70M
Gross Profit: $40.83M (67.27 %)
EPS: $0.630

Financial Reports:

No articles found.

Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators